Journal of Autoimmunity

Papers
(The TQCC of Journal of Autoimmunity is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The 2022 outbreak and the pathobiology of the monkeypox virus320
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19230
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses210
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies178
Complement activation and endothelial perturbation parallel COVID-19 severity and activity127
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection123
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy106
Ferritin – from iron, through inflammation and autoimmunity, to COVID-19102
COVID-19 convalescent plasma composition and immunological effects in severe patients95
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups91
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination89
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?78
Autoimmune hepatitis after COVID-19 vaccine – more than a coincidence75
Auto-immune hepatitis following COVID vaccination72
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature69
Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial68
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients68
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination67
Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies67
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-1959
Lupus nephritis: new progress in diagnosis and treatment58
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review58
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?57
Marginal zone B cells: From housekeeping function to autoimmunity?55
Resistant starch intake alleviates collagen-induced arthritis in mice by modulating gut microbiota and promoting concomitant propionate production55
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab53
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data52
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis51
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases48
The complement system and human autoimmune diseases47
Perspectives on vaccine induced thrombotic thrombocytopenia47
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data47
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target47
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development47
Regulatory T cells in autoimmune hepatitis: an updated overview46
New developments implicating IL-21 in autoimmune disease46
Mushrooms and immunity45
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-1944
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study44
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus43
Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications42
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study42
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients42
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers41
Intestinal permeability in type 1 diabetes: An updated comprehensive overview40
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination39
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p38
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals38
Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome37
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study37
Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines37
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation35
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis34
Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature33
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score33
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy32
Pathogenesis, multi-omics research, and clinical treatment of psoriasis32
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak32
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-1931
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities30
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?30
Autoimmune dysautonomia in women with silicone breast implants30
Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients29
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications29
Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects27
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status27
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis27
T follicular helper cells in autoimmune diseases26
Transcriptome landscape of double negative T cells by single-cell RNA sequencing26
Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle26
Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression26
Gut microbiota in systemic lupus erythematosus: A fuse and a solution25
T helper cell immunity in pregnancy and influence on autoimmune disease progression25
Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis25
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network25
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort25
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center24
Fecal microbiota transplantation: Emerging applications in autoimmune diseases24
Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis23
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis23
Molecular mimicry and autoimmunity in the time of COVID-1923
Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica23
Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases23
Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs23
Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways22
Autophagy pathways in autoimmune diseases22
Pre-existing conditions associated with post-acute sequelae of COVID-1922
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients21
B cell-targeted therapies in systemic lupus erythematosus21
Infectious diseases, autoantibodies, and autoimmunity21
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production21
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis21
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review21
Telomeres: New players in immune-mediated inflammatory diseases?21
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study20
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment20
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong20
Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study19
Interferon signature in giant cell arteritis aortitis19
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis19
The gut ecosystem and immune tolerance18
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis18
Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases18
Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review18
Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes18
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine17
HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes17
Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark17
Advances in SLE classification criteria17
Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera17
Influence of X chromosome in sex-biased autoimmune diseases16
Flagellin-specific human CAR Tregs for immune regulation in IBD16
Autoreactive T cells and their role in atopic dermatitis16
Involvement of trained immunity during autoimmune responses16
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines16
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application16
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis15
Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus15
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases15
Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases15
Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis15
ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP15
Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases15
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus15
Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes15
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease15
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function14
Cognitive dysfunction in SLE: An understudied clinical manifestation14
Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study14
Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer14
Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes14
Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus14
Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease14
0.03758716583252